What is CONMED's revenue?

CONMED (CNMD) generated $1.4B in revenue over the trailing twelve months, up 4.1% year over year.

Is CONMED profitable?

CONMED reported $54.8M in net income over the trailing twelve months, a 4.0% net margin.

What are CONMED's profit margins?

Gross margin is 55.2% and operating margin is 8.2%, with a 4.0% net margin.

What is CONMED's earnings per share?

CONMED's diluted EPS over the trailing twelve months is $1.77.

Where does CONMED's income statement data come from?

Every line is extracted from CONMED's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

CONMED CNMD Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$1.37B+5.2%	$1.31B+5.0%	$1.24B+19.1%	$1.05B+3.4%
Total cost of revenue	$624.25M+8.8%	$573.98M+1.0%	$568.5M+19.9%	$474.23M+7.1%
Gross profit	$750.48M+2.4%	$733.03M+8.4%	$676.25M+18.4%	$571.25M+0.6%
Gross margin	54.6%-1.5pp	56.1%+1.8pp	54.3%-0.3pp	54.6%-1.6pp
Research and development	$55.89M+2.7%	$54.43M+3.5%	$52.6M+11.6%	$47.15M+8.2%
Selling, general and administrative	$591.97M+23.8%	$478.28M-4.9%	$503.04M+10.8%	$454.04M+9.5%
Selling and marketing	$67.25M+2.9%	$65.34M+7.3%	$60.92M+8.7%	$56.03M—
General and administrative	$131.97M+12.3%	$117.46M+5.6%	$111.24M+15.7%	$96.11M—
Total operating expenses	$647.85M+21.6%	$532.71M-4.1%	$555.64M+10.9%	$501.19M+9.4%
Operating income	$102.62M-48.8%	$200.33M+66.1%	$120.6M+69.5%	$71.15M-35.2%
Operating margin	7.5%-7.9pp	15.3%+5.6pp	9.7%+2.9pp	6.8%-4.1pp
Interest expense	$31.09M-16.6%	$37.3M-6.2%	$39.78M+37.6%	$28.91M-18.5%
Other income (expense), net	$170K-94.0%	$2.83M-82.2%	$15.94M+88.0%	$8.48M—
Income before income taxes	$71.12M-56.4%	$163.03M+102%	$80.83M+214%	-$70.86M-197%
Income tax expense	$24.06M-21.4%	$30.61M+87.0%	$16.37M—	——
Net income	$47.06M-64.5%	$132.42M+105%	$64.46M—	——
Net margin	3.4%-6.7pp	10.1%+5.0pp	5.2%—	——
Diluted earnings per share	$1.51-64.4%	$4.24+108%	$2.04—	——
EBITDA	$154.97M-38.4%	$251.63M+46.3%	$172M+42.3%	$120.91M-24.2%
EBITDA margin	11.3%-8.0pp	19.3%+5.4pp	13.8%+2.3pp	11.6%-4.2pp
EBIT	$102.62M-48.8%	$200.33M+66.1%	$120.6M+69.5%	$71.15M-35.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about CONMED.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CONMED's revenue?: CONMED (CNMD) generated $1.4B in revenue over the trailing twelve months, up 4.1% year over year.
Is CONMED profitable?: CONMED reported $54.8M in net income over the trailing twelve months, a 4.0% net margin.
What are CONMED's profit margins?: Gross margin is 55.2% and operating margin is 8.2%, with a 4.0% net margin.
What is CONMED's earnings per share?: CONMED's diluted EPS over the trailing twelve months is $1.77.
Where does CONMED's income statement data come from?: Every line is extracted from CONMED's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.